Importance of stereospecific bionalytical monitoring in drug development
- 1 January 1996
- journal article
- review article
- Published by Elsevier in Journal of Chromatography A
- Vol. 719 (1) , 3-13
- https://doi.org/10.1016/0021-9673(95)00465-3
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- An Introduction to Drug Disposition: The Basic Principles of Absorption, Distribution, Metabolism, and ExcretionToxicologic Pathology, 1995
- A predictive model for substrates of cytochrome P450-debrisoquine (2D6)Chemical Research in Toxicology, 1992
- Stereoselective aliphatic hydroxylation of 6‐n‐propylchromone‐2‐carboxylic acid by female Dutch rabbitsChirality, 1992
- Racemic mixtures and single stereoisomers: Industrial concerns and issues in drug developmentChirality, 1991
- Comparative effects of the diastereoisomers, quinine and quinidine in producing phenocopy debrisoquine poor metabolisers (PMs) in healthy volunteersChirality, 1991
- Enantiomers in arthritic disordersPharmacology & Therapeutics, 1990
- Racemates versus enantiomers in drug development: Dogmatism or pragmatism?Chirality, 1990
- Racemates: towards a new year resolution?Trends in Pharmacological Sciences, 1988
- Clinical pharmacology. Adverse reactions to drugs.BMJ, 1981
- Effect of route of administration and distribution on drug actionJournal of Pharmacokinetics and Biopharmaceutics, 1978